Morphic Holding, Inc. Gains 75.06%
Mon, Jul 08, 2024 at 07:20 PM
Morphic Holding, Inc. (MORF:NASDAQ) jumped higher at $55.74, a gain of 75.1%. On Mon, Jul 08, 2024, MORF:NASDAQ hit a New 2-Week High of $55.74. The stock got featured on our News Catalysts scanner on Mon, Jul 08, 2024 at 04:51 PM in the 'ACQUISITION' category. From Mon, Jun 24, 2024, the stock recorded 66.67% Up Days and 50.00% Green Days
About Morphic Holding, Inc. (MORF:NASDAQ)
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer.
Top 10 Gainers:
- Shapeways Holdings Inc. (SHPW:NASDAQ), 132.19%
- Shapeways Holdings Inc. (SHPW:NYSE), 132.19%
- Zapp Electric Vehicles Group Limited (ZAPP:NASDAQ), 127.03%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 99.33%
- Virpax Pharmaceuticals Inc. (VRPX:NASDAQ), 92.04%
- Morphic Holding, Inc. (MORF:NASDAQ), 75.06%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- Bite Acquisition Corp. (BITE:NYSEMKT), 43.68%
- Bite Acquisition Corp. (BITE:NYSE), 43.68%
- Myomo, Inc. (MYO:NYSEMKT), 41.81%